Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move - (CSE:
$SOL.C) (TSXV: $DN.V) (TSX: $WEED.TO) (NYSE: CGC) (TSXV: $NRTH.V)
Delta, Kelowna, BC –August
9, 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news
source covering leading sectors including marijuana and hemp stocks and its
potcast site, www.potcasts.ca release today’s edition of Investorideas.com potcastsCM -
cannabis news and stocks to watch plus insight from thought leaders and
experts.
Listen to the
podcast:
Read this in full
at https://www.investorideas.com/news/2019/cannabis-potcasts/08091SOL-DN-WEED-CGC-NRTH.asp
Today's podcast overview/transcript:
Good afternoon and welcome to another episode of
Investorideas.com "Potcast" featuring cannabis news, stocks to watch
as well as insights from thought leaders and experts.
In
today’s podcast we look at a few early announcements.
SOL
Global Investments Corp. (CSE:SOL) (OTCPK:SOLCF) announced
today a proposed change of business of SOL
Global from an international cannabis investment company to a U.S. multi-state
cannabis operator ("MSO")
under the Life Sciences category of the Canadian Securities Exchange.
The MSO's initial operations will include
assets in three (3) of the top ten (10) cannabis markets by revenue in the
U.S., as forecasted by ArcView market research – Florida, Michigan and
California. The Company has focused in
on a path to profitability by keeping the capital expense and operating expense
low with an efficiency-driven model of integrating operations and streamlining
management, brand deployment and the Company's proprietary delivery models
across all three (3) states, all while being fully compliant with applicable
U.S. state laws and regulations.
Brady Cobb, the CEO of SOL Global, says
the timing of the proposed change of business is strategic, stating: "One
of the innate strengths of SOL Global's management is knowing when to enter a
market, as is evidenced with our early success in Canada and Florida. We have
planned this transition and the market entrance of our MSO to coincide with the
rapid growth of the legal U.S. cannabis marketplace amid a presumptive tail
wind from federal policy reform initiatives related to cannabis, a process I've
been deeply involved with. We believe that the timing of our MSO's entrance
into the market will position us well to capture that growth."
Tantamount to the proposed change of
business is the proposed change of the Company's name from SOL Global
Investments Corp. to Bluma Wellness Inc. "Bluma" is an ancient Hebrew
word which means to flower, bloom or blossom. The Company selected this name
based on a key principle of the business: to ensure that our patients and
consumers utilize our plant-based products to enhance their daily lives, namely
to bloom and thrive.
Mr. Cobb says that the new name was
chosen to be synergistic with the Company's new direction, stating that
"We chose the name Bluma Wellness, as an appropriate way to honor the true
intent of each seed that we cultivate, harvest, and deliver as a product to
ensure that every single one of our customers has a consistent and enriching
experience that allows them to flourish." He added: "We also look
forward to bringing investors a new kind of MSO, one that is focused on
profitability in the short term through operational and logistical efficiencies
and a keen eye on the bottom line."
As part of the Company's initiative in
shifting their focus of business to the vertically integrated expansion of its
MSO operations, the Company plans to complete the previously-announced
acquisitions of the proposed assets of the MSO which include the licensed
dispensaries operated by MCP Wellness in Michigan as announced on April 24,
2019, their California acquisitions which include the famed Humboldt,
California-based cultivator "Northern Emeralds" and the
California-based dispensary chain "One Plant USA" as were announced
on May 16, 2019, in addition to SOL Global's existing vertically integrated
license in Florida, 3 Boys Farm. The MSO's resulting products will be powered
by Northern Emeralds' genetics and innovative data-driven cultivation and
processing techniques. The anchor will be the brands and products that SOL
Global has invested in, which will be strategically deployed in the MSO's
dispensaries including One Plant's robust retail arm across the states of
Florida, Michigan and California (subject to the receipt of all required
governmental approvals).
It is expected that the MSO will bridge
the gap between traditional THC products and mainstay CPG products. All MSO Assets transactions are expected to
close in October 2019, subject to all applicable conditions precedent being
satisfied or waived including the receipt of all required governmental
approvals.
DELTA
9 CANNABIS INC. (TSX-V:
DN) (OTCQX:
VRNDF) announced that
is has received conditional approval from the Toronto Stock Exchange to
graduate from the TSX Venture Exchange and list its common shares on the TSX.
"We are very excited to be in the
final stages of qualifying to be up listed to the TSX. This is a major
milestone in our strategic growth plan and for our shareholders," said
John Arbuthnot, Chief Executive Officer of Delta 9. "This eventual listing
on the TSX will help to increase trading liquidity, provide access a growing
investor base interested in the cannabis industry, and raise capital for
further investments."
Final approval of the listing is subject
to the Company meeting certain standard requirements of the TSX on or before
November 5, 2019. The Company expects to satisfy all of the requirements and
will make a further announcement once the TSX has issued a bulletin confirming
the date on which trading on the TSX will commence. Upon completion of the
final listing requirements, the Common Shares, 2017 Warrants, 2019 Warrants and
Debentures will be delisted from the TSXV and begin trading on the TSX under
the symbols, "DN", "DN.WT", "DN.WT.A" and
"DN.DB", respectively.
"As one of Canada's only vertically
integrated cannabis companies, we are excited about the opportunities in this
rapidly growing market to drive shareholder value and continue Delta 9's
success story. The TSX is the premier listings destination and this achievement
highlights the strength of our experienced management and team, our commitment
to growing shareholder value," said John Arbuthnot, Chief Executive
Officer of Delta 9.
Canopy
Growth Corporation (TSX:
WEED) (NYSE:
CGC)
announced that it has entered into an agreement to
acquire the global cannabinoid-based medical researcher Beckley Canopy
Therapeutics. The acquisition brings together Canopy's wholly owned research
program with the Beckley Canopy research platform which is partly owned by
Canopy Growth in order to combine the best teams, programs and clinical work
all under a single strategic plan. The research arm in turn directly supports
the commercial efforts of Spectrum Therapeutics around the world. As part of
the acquisition, Canopy Growth also acquires the outstanding shares in Spectrum
Biomedical UK, the commercial arm of the Company in the United Kingdom, as that
markets begins to develop into a commercially viable opportunity.
With the acquisition of C3, and Canopy Growth's expanding research and development
plans worldwide, the Company is solidifying its status as a truly global leader
in cannabinoid research. Spectrum Therapeutics will leverage Beckley Canopy's
intellectual property, accelerate its comprehensive research programs, build evidence
around the Company's products and formulations and ultimately improve patient
access to cannabinoid-based medicines globally.
"The acquisition of Beckley Canopy
will allow Spectrum Therapeutics to continue expanding its medical cannabis
leadership around the world, strengthening our foothold in the UK and more
broadly across Europe – a region that wants to see stronger clinical evidence
around cannabis-based medicines," said Mark Zekulin, CEO, Canopy Growth
Corporation. "We're excited to continue working with the incredible
management team at Beckley Canopy to accelerate our shared vision to create
evidence-based cannabis formulations that will serve patients in need around
the world."
Beckley Canopy was formed as a joint venture in January 2018 between Beckley
Research & Innovations ("BRI") and Canopy Growth to research and
develop clinically validated cannabis-based medicines, with a strong focus on
intellectual property protection. The research platform combined European and
North American-based leaders in cannabis research from BRI and Canopy Growth to
create a strong and complementary UK-based European partnership. Since its
inception, Beckley Canopy has made significant progress in three initial areas
of research, namely cancer pain, opioid sparing, and smoking cessation, with
further research in progress.
Once the acquisition is complete, Beckley
Canopy will be fully integrated into the current Spectrum Therapeutics platform
and management team in Europe, a region of focus for the Company as policy
surrounding medical cannabis and patient access continues to evolve. The
leadership team at Beckley Canopy has demonstrated a strong track record of
success in the short period since its inception, and the senior research team
boasts a combined 75 years of pharmaceutical research globally.
48North
Cannabis Corp. (TSXV:NRTH) announced
today that it has successfully shipped its
first order of cannabis to the Ontario Cannabis Store ("OCS") for
retail sale. The shipment marks the Company's first foray into Ontario's
recreational retail market.
Today's shipment is just the beginning of
the Company's relationship with the OCS. Looking ahead, 48North has agreed to
supply 1,200 kilograms of sun-grown outdoor organic cannabis from Good:Farm and
180 kilograms of its high-quality craft indoor-grown cannabis from its northern
cultivation facility, delshen. Today's
shipment pertains to the 180 kilograms from its indoor facilities.
"48North is looking forward to
sharing our high-quality cannabis with Ontario consumers. Today's shipment
marks a major milestone for the Company. As we look ahead, the Company is
well-prepared to deliver on all of its supply agreements, we look forward to
sharing our products with consumers across the country," said Alison
Gordon, co-CEO of 48North.
By the end of the year, 48North products
will be available for retail sale in Ontario, Alberta and Quebec. 48North has
committed approximately 5,000 kilograms of cannabis from its three facilities
to provincial distributors in 2019.
Investor ideas reminds all listeners to read our disclaimers and disclosures
on the
Investorideas.com website and this podcast is not an endorsement
to buy products or services or securities. Investors are reminded all
investment involves risk and possible loss of investment
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also
available on iTunes, Spotify, Google
Play Music, Stitcher, Spreaker, YouTube
via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark
on the blockchain through Cognate, Inc. CM Certification-Registration Number:
10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news
source publishing third party news and press releases plus we create original
financial content. Learn about investing in stocks and sector trends
from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto,
technology including AI and IoT ,
mining ,sports biotech, water, renewable energy and more . Investorideas.com
original branded content includes the daily Crypto Corner and Podcast, Play
by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News
and Stocks on the Move podcast and column,
Cleantech and Climate Change Podcast and
the AI
Eye Podcast and column covering developments in
AI.
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn
more about publishing your news release and our other news services on the
Investorideas.com newswire https://www.investorideas.com/News-Upload/ and
tickertagstocknews.com
Global investors must adhere to regulations of each
country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where
permissible by law. Our site does not possess, distribute, or sell cannabis
products.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
